SG Americas Securities’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $621K | Sell |
6,900
-109,500
| -94% | -$111M | ﹤0.01% | 2059 |
|
|
2025
Q4 | $9.51M | Buy |
116,400
+53,200
| +84% | +$50.9M | 0.01% | 791 |
|
|
2025
Q3 | $3.78M | Buy |
63,200
+38,500
| +156% | +$28.7M | 0.01% | 621 |
|
|
2025
Q2 | $3M | Sell |
24,700
-26,700
| -52% | -$20.7M | 0.01% | 624 |
|
|
2025
Q1 | $3.69M | Sell |
51,400
-119,900
| -70% | -$99.8M | 0.01% | 571 |
|
|
2024
Q4 | $5.94M | Buy |
171,300
+55,800
| +48% | +$46.2M | 0.02% | 319 |
|
|
2024
Q3 | $17.6M | Buy |
115,500
+62,100
| +116% | +$55.8M | 0.06% | 183 |
|
|
2024
Q2 | $12.6M | Buy |
53,400
+8,000
| +18% | +$6.4M | 0.07% | 275 |
|
|
2024
Q1 | $7.31M | Sell |
45,400
-34,100
| -43% | -$24.3M | 0.04% | 450 |
|
|
2023
Q4 | $2.92M | Sell |
79,500
-77,000
| -49% | -$44.9M | 0.03% | 516 |
|
|
2023
Q3 | $1.06M | Sell |
156,500
-65,400
| -29% | -$33.7M | 0.01% | 1211 |
|
|
2023
Q2 | $8.69M | Buy |
221,900
+191,900
| +640% | +$80.5M | 0.07% | 208 |
|
|
2023
Q1 | $515K | Sell |
30,000
-500
| -2% | -$169K | 0.01% | 1693 |
|
|
2022
Q4 | $503K | Buy |
30,500
+20,000
| +190% | +$7.09M | 0.01% | 1526 |
|
|
2022
Q3 | $201K | Sell |
10,500
-80,000
| -88% | -$25.3M | ﹤0.01% | 2316 |
|
|
2022
Q2 | $2.44M | Buy |
90,500
+85,000
| +1,545% | +$25.5M | 0.03% | 629 |
|
|
2022
Q1 | $134K | Buy |
+5,500
| New | +$1.42M | ﹤0.01% | 2650 |
|
|
2021
Q3 | – | Sell |
-140,000
| Closed | -$1.14M | – | 3867 |
|
|
2021
Q2 | $1.14M | Sell |
140,000
-50,000
| -26% | -$10M | 0.01% | 1477 |
|
|
2021
Q1 | $36K | Buy |
+190,000
| New | +$37.2M | ﹤0.01% | 3183 |
|
|
2020
Q2 | – | Sell |
-46,500
| Closed | -$505K | – | 3780 |
|
|
2020
Q1 | $505K | Sell |
46,500
-124,800
| -73% | -$17.1M | ﹤0.01% | 1839 |
|
|
2019
Q4 | $577K | Buy |
171,300
+70,000
| +69% | +$8.11M | 0.01% | 1653 |
|
|
2019
Q3 | $153K | Sell |
101,300
-13,700
| -12% | -$1.53M | ﹤0.01% | 2498 |
|
|
2019
Q2 | $168K | Sell |
115,000
-233,100
| -67% | -$27.4M | ﹤0.01% | 2522 |
|
|
2019
Q1 | $2.1M | Buy |
348,100
+47,200
| +16% | +$5.74M | 0.02% | 815 |
|
|
2018
Q4 | $1.66M | Buy |
300,900
+45,000
| +18% | +$5.03M | 0.01% | 1002 |
|
|
2018
Q3 | $1.97M | Buy |
255,900
+175,000
| +216% | +$17.5M | 0.01% | 1182 |
|
|
2018
Q2 | $560K | Sell |
80,900
-109,600
| -58% | -$9M | 0.01% | 1927 |
|
|
2018
Q1 | $451K | Buy |
190,500
+56,300
| +42% | +$4.53M | ﹤0.01% | 1936 |
|
|
2017
Q4 | $826K | Buy |
134,200
+50,000
| +59% | +$4.25M | 0.01% | 1515 |
|
|
2017
Q3 | $749K | Buy |
84,200
+10,500
| +14% | +$861K | 0.01% | 1491 |
|
|
2017
Q2 | $662K | Sell |
73,700
-70,000
| -49% | -$5.71M | 0.01% | 1680 |
|
|
2017
Q1 | $875K | Buy |
143,700
+36,500
| +34% | +$2.92M | 0.01% | 1472 |
|
|
2016
Q4 | $506K | Buy |
107,200
+93,700
| +694% | +$6.98M | ﹤0.01% | 1692 |
|
|
2016
Q3 | $19K | Hold |
13,500
| – | – | ﹤0.01% | 3252 |
|
|
2016
Q2 | $16K | Sell |
13,500
-100,000
| -88% | -$7.53M | ﹤0.01% | 2520 |
|
|
2016
Q1 | $16K | Buy |
+113,500
| New | +$8.59M | ﹤0.01% | 2852 |
|
|
2015
Q1 | – | Sell |
-27,700
| Closed | -$68K | – | 2842 |
|
|
2014
Q4 | $68K | Sell |
27,700
-21,400
| -44% | -$1.44M | ﹤0.01% | 2979 |
|
|
2014
Q3 | $294K | Hold |
49,100
| – | – | ﹤0.01% | 1776 |
|
|
2014
Q2 | $230K | Hold |
49,100
| – | – | ﹤0.01% | 1974 |
|
|
2014
Q1 | $169K | Buy |
49,100
+10,100
| +26% | +$564K | ﹤0.01% | 2005 |
|
|
2013
Q4 | $48K | Buy |
+39,000
| New | +$1.95M | ﹤0.01% | 2469 |
|
Other funds holding LLY
VCM
VPM
SG Americas Securities's LLY Position: Q1 2026 in Review
SG Americas Securities increased its Eli Lilly (LLY) stake by 155% in Q1 2026, buying an estimated $402M and bringing the position to 652,281 shares worth $600M. The position accounts for 0.65% of the portfolio, ranked #21.
SG Americas Securities first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- SG Americas Securities held 652,281 shares of Eli Lilly worth $600M as of Q1 2026.
- SG Americas Securities bought 396,357 Eli Lilly shares in Q1 2026, an estimated $402M.
- Eli Lilly made up 0.65% of SG Americas Securities's portfolio in Q1 2026, its #21 holding.
- SG Americas Securities first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.